West Bengal Set to Implement PM Vishwakarma Scheme for Artisan Support Following Central Approval US April Payrolls Surge Beyond Expectations Yet Economic Undercurrents Raise Concerns European Companies Pursue Reindustrialisation Amid Declining Investment Plans and AIs Rising Role LICs Valuation Cheap PE Masks Potential Expense Based on VNB Metrics Summer Electricity Costs Climb as Heat Waves Drive Up Cooling Demand Inflation Strains Holiday Weekend Budgets as Travel Recreation and Food Prices Rise Most CACI Q1 2026 Earnings EPS Beat Drives Positive Early Trading BZAI Q1 2026 Earnings EPS Beat Amid Revenue Discontinuation Shares Surge MeiraGTx Holdings plc MGTX Q1 2026 Earnings WiderthanExpected Loss Amid Clinical Progress Sound Point Meridian Capital Inc Q1 2026 Earnings Earnings Miss as EPS Falls Short of Estimates BioAge Labs Q1 2026 Earnings Narrower Loss Delivers Positive Surprise as PreRevenue Biotech Advances Pipeline STKS Q1 2026 Earnings EPS Misses Estimates as Company Faces Operating Headwinds Taylor Devices TAYD Holds Steady Near Support as Momentum Builds Mercury General MCY Holds Steady Near 102 After Modest Advance Select Medical Holdings SEM Holds Steady Near 1652 as Traders Eye Key Levels Procter Gamble PG Edges Higher Amid Defensive Appeal Holds Near MidRange Scage Future SCAG Slides 4 Nears Critical Support at 047 The TrillionDollar Question SpaceX Starship Test and Its IPO Implications AMTD IDEA Group Q4 2020 Earnings EPS Surges 8093 Above Estimates Amid Mixed Market Response Logitech LOGI Slips Slightly Support Test Looms Near 10475 ProQR Therapeutics Q1 2026 Earnings Narrower Net Loss No Revenue as Pipeline Progress Drives Stock Gains LGN Q1 2026 Earnings EPS Misses Estimates Despite Positive Market Reaction TaoWeave Inc TWAV Q3 2022 Earnings Significant EPS Miss Sends Stock Lower CATX Q1 2026 Earnings Narrower Loss Fails to Lift PreRevenue Biotech CMCL Q1 2026 Earnings Slight EPS Miss Amid Unreported Revenue Stock Declines MHLA Q3 2024 Earnings Underlying Company Reports Negative EPS No Revenue Data Available ALEC Q1 2026 Earnings NarrowerThanExpected Loss Highlights Progress in Neurodegenerative Pipeline